发明名称 DNA-PK inhibitors
摘要 A compound of formula I: and isomers, salts, solvates, chemically protected forms, and prodrugs thereof, wherein: R1 and R2 are independently selected from hydrogen, an optionally substituted C1-7 alkyl group, C3-20 heterocyclyl group, or C5-20 aryl group, or may together form, along with the nitrogen atom to which they are attached, an optionally substituted heterocyclic ring having from 4 to 8 ring atoms; Q is —NH—C(═O)— or —O—; Y is an optionally substituted C1-5 alkylene group; X is selected from SR3 or NR4R5, wherein, R3, or R4 and R5 are independently selected from hydrogen, optionally substituted C1-7 alkyl, C5-20 aryl, or C3-20 heterocyclyl groups, or R4 and R5 may together form, along with the nitrogen atom to which they are attached, an optionally substituted heterocyclic ring having from 4 to 8 ring atoms; if Q is —O—, X is additionally selected from —C(═O)—NR6R7, wherein R6 and R7 are independently selected from hydrogen, optionally substituted C1-7 alkyl, C5-20 aryl, or C3-20 heterocyclyl groups, or R6 and R7 may together form, along with the nitrogen atom to which they are attached, an optionally substituted heterocyclic ring having from 4 to 8 ring atoms; and if Q is —NH—C(═O)—, —Y—X may additionally be selected from C1-7 alkyl.
申请公布号 US7732483(B2) 申请公布日期 2010.06.08
申请号 US20080133837 申请日期 2008.06.05
申请人 KUDOS PHARMACEUTICALS LIMITED;CANCER RESEARCH TECHNOLOGY LIMITED 发明人 SMITH GRAEME CAMERON MURRAY;MARTIN NIALL MORRISON BARR;MENEAR KEITH ALLAN;HUMMERSONE MARC GEOFFREY;RIGOREAU LAURENT JEAN MARTIN;GRIFFIN ROGER JOHN;GOLDING BERNARD THOMAS;NEWELL DAVID RICHARD;CALVERT HILARY ALAN;CURTIN NICOLA JANE;HARDCASTLE IAN ROBERT;SARAVANAN KAPPUSAMY
分类号 A61K31/381;C07D333/74;C07D409/04 主分类号 A61K31/381
代理机构 代理人
主权项
地址